---
title: Hyper-Dependence on NHEJ Enables Synergy Between DNA-PK Inhibitors and Low-Dose
  Doxorubicin in Leiomyosarcoma
date: '2023-09-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37773632/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230930180856&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Combinations of DNA-PK inhibitors with unconventionally
  low, sensitizing, doxorubicin dosing showed synergistic effects in LMS in vitro
  and in vivo models, without discernable toxicity. These findings underscore the
  relevance of DNA damage repair alterations in LMS pathogenesis and identify dependence
  on NHEJ as a clinically actionable vulnerability in ...'
disable_comments: true
---
CONCLUSION: Combinations of DNA-PK inhibitors with unconventionally low, sensitizing, doxorubicin dosing showed synergistic effects in LMS in vitro and in vivo models, without discernable toxicity. These findings underscore the relevance of DNA damage repair alterations in LMS pathogenesis and identify dependence on NHEJ as a clinically actionable vulnerability in ...